Statistics

Total Visits

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies7

Select a period of time:

Number of views in the range

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies5

Views

Views
November 20231
December 20230
January 20241
February 20241
March 20242
April 20240
May 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Hong Kong2
 

Top cities views

Views
Central2
Boardman1